<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/ikt" ></link>
<id>urn:uuid:0486d2b6-d7cd-a8f4-5fa3-4564d4d9e577</id>
<updated>2026-06-27T13:11:31-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>IKT: AURENTZ VINCENT (DIR) Disposed (JS) 255,299 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339719" ></link>
<id>urn:uuid:5270e5c4-5d48-ee39-d341-e55d4bbec782</id>
<updated>2026-02-24T20:54:26-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: CABELL CHRISTOPHER (PR) Disposed (JS) 338,282 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339724" ></link>
<id>urn:uuid:44c71558-6a34-2121-dffc-abe4886c2e49</id>
<updated>2026-02-24T20:53:37-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: MUNSHI AMIT (DIR) Disposed (JS) 19,089 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339713" ></link>
<id>urn:uuid:26737d9b-497b-ae91-b44b-ec44f41dd060</id>
<updated>2026-02-24T20:48:55-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: SANDS CAPITAL LIFE SCIENCES PULSE FUND II L P (BO) Bought (JB*) 2.1mm Shares of INHIBIKASE THERAPEUTICS INC for $1.45 on 11/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6281095" ></link>
<id>urn:uuid:064ac8b6-5b88-41f5-9a61-aed30e16ab60</id>
<updated>2025-11-24T15:47:02-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: CABELL CHRISTOPHER (PR) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 1.0mm</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247609" ></link>
<id>urn:uuid:cc9b7587-c8be-eec2-5053-eb036f47d5c8</id>
<updated>2025-08-28T19:52:09-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: AURENTZ VINCENT (DIR) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 765,895</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247608" ></link>
<id>urn:uuid:5e4784ea-6af2-db04-d602-c0d0d626416c</id>
<updated>2025-08-28T19:50:18-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: MUNSHI AMIT (DIR) Acquired (JB) 57,265 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247610" ></link>
<id>urn:uuid:da10ef1c-c9f3-d008-72c3-6989eab25db0</id>
<updated>2025-08-28T19:48:20-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: SANDS CAPITAL LIFE SCIENCES PULSE FUND II L P (BO) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 11.0mm</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6229037" ></link>
<id>urn:uuid:8c042154-dea5-9ccf-955d-ba997c2f9ca5</id>
<updated>2025-07-15T11:15:44-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: MCINTYRE DAVID (CFO) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 10,285</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6183484" ></link>
<id>urn:uuid:7d54424a-caab-dde0-3847-fb1c87d259ed</id>
<updated>2025-04-16T16:05:04-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
<entry>
<title>IKT: CABELL CHRISTOPHER (PR) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6143301" ></link>
<id>urn:uuid:c237d338-9218-f84a-a53a-ca6197ad7b54</id>
<updated>2025-02-25T16:05:22-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $1.91. Mkt Cap:252.2mm. 10D Vol: 1.0mm]]></summary>
</entry>
</feed>